RACHEL KELLER: Open Payments
NPI 1366969735 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 73 payments from 17 companies in 2025. Trend: 2023 $431 · 2024 $1,022 · 2025 $1,420
Food & beverage: $1,420
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $329 |
| LEO Pharma Inc. | 12 | $201 |
| Janssen Biotech, Inc. | 13 | $186 |
| Regeneron Healthcare Solutions, Inc. | 7 | $162 |
| LNHC, Inc | 4 | $99 |
| Incyte Corporation | 3 | $87 |
| Organon LLC | 7 | $61 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
Products named: DUPIXENT, ADBRY, TREMFYA, ZELSUVMI, LIBTAYO, JAKAFI, Cabtreo, SPEVIGO.
Industry payments across FL — which companies pay providers there.
